within Pharmacolibrary.Drugs.D_Dermatologicals.D04A_AntipruriticsInclAntihistaminesAnestheticsEtc.D04AA16_Pheniramine;

model Pheniramine
  extends Pharmacolibrary.Drugs.ATC.D.D04AA16;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D04AA16</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pheniramine is a first-generation antihistamine of the alkylamine class used to treat allergic conditions such as hay fever, urticaria, and allergic conjunctivitis. It is also used as an antiallergic and antipruritic agent. While pheniramine has seen widespread use in over-the-counter preparations, in some countries it is less commonly used today with second-generation antihistamines often being preferred due to lower sedation.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult population, as specific published human PK parameters for pheniramine are not directly available.</p><h4>References</h4><ol><li><p>Witte, PU, et al., &amp; Hajdú, P (1985). Pharmacokinetics of pheniramine (Avil) and metabolites in healthy subjects after oral and intravenous administration. <i>International journal of clinical pharmacology, therapy, and toxicology</i> 23(1) 59–62. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3988394/\">https://pubmed.ncbi.nlm.nih.gov/3988394</a></p></li><li><p>Pathirana, S, et al., &amp; Thompson, GA (2018). Brompheniramine and Chlorpheniramine Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 Years. <i>Journal of clinical pharmacology</i> 58(4) 494–503. DOI:<a href=\"https://doi.org/10.1002/jcph.1037\">10.1002/jcph.1037</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29136286/\">https://pubmed.ncbi.nlm.nih.gov/29136286</a></p></li><li><p>Kuroda, T, et al., &amp; Hariu, K (2013). Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses. <i>Veterinary journal (London, England : 1997)</i> 197(2) 433–437. DOI:<a href=\"https://doi.org/10.1016/j.tvjl.2013.02.003\">10.1016/j.tvjl.2013.02.003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23489843/\">https://pubmed.ncbi.nlm.nih.gov/23489843</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Pheniramine;
